Friday, May 30, 2025 at 6:30pm CT
Posted
by
Med Learning Group
on
5/22/2025
Description
The goal of this program is to increase the health care professional’s ability to: analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors and identify potential adverse events.
Clinical topics
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Colon Cancer
Gastric Cancer
Lung Cancer
Oncology
Prostate Cancer
Specialties
Acute Care
Ambulatory Care
Correctional Nursing
Critical Care
Educational/Research
Emergency/Trauma
Endocrinology
Family
Gastroenterology
Geriatrics
Hematology / Oncology
Holistic Nursing
Home Health
Long Term Care
Medical/Surgical
Nursing Student
Occupational/Public Health